4th Annual Transdermal and Microneedle Drug Delivery

4th Annual Transdermal and Microneedle Drug Delivery is organized by SAE Media Group (SMG) and will be held from Nov 10 - 11, 2025 at Hilton London Kensington, London, England, United Kingdom.

Description:
Engage with leading drug development and delivery leaders in a dynamic, expert-led environment. This conference brings together forward-thinking innovators to explore cutting-edge case studies, breakthrough vaccine and therapeutic applications, and the evolving capabilities of transdermal and microneedle technologies.

Transdermal and microneedle patches are hold opportunity to ‘go beyond the needle’ and revolutionise pharmaceutical development, offering enhanced accessibility, and long-term delivery solutions. With applications ranging from improved vaccine distribution to advanced diagnostics, these technologies are able to reshape healthcare by increasing efficacy and expanding global access to life-changing treatments.

Key Topics & Discussions:

• Breakthroughs in Clinical Data & Vaccine Delivery – Examining real-world success stories and research-backed evidence.
• Innovative Capabilities & Applications – Exploring how transdermal and microneedle patches are unlocking new therapeutic possibilities.
• Manufacturing Challenges & Progress – Addressing scalability, regulatory compliance, and formulation advancements.
• Regulatory Insights & Expert Q&A – Engaging with key regulators and industry leaders to navigate development, approval pathways and market adoption.

Highlights for 2025:

• Engage the evolving transdermal and microneedle market with expert insights into emerging trends and innovations.
• Learn about novel drug delivery applications, from biologics to small molecules, and their clinical impact.
• Uncover best practices, regulatory considerations, and technical advancements in microarray patch technology.
• Dive into the latest developments in transdermal and microneedle-based vaccines, optimizing accessibility and efficacy.
• Network with pharma, biotech, device developers, and regulatory experts driving next-generation drug delivery innovations.